However, based on the findings described above regarding the effector functions of differentially glycosylated IgG Abs, it is questionable whether an anti-tumor IgG1 Ab and an anti-RhD IgG1 Ab should have the same Fc glycosylation. Here, RHD is linked to neoplasm.